Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Lymphoma

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 27 articles: HTML format

Single Articles

April 2026
1. HIRABAYASHI M, Georges D, Combes JD, Clifford GM, et al
   Attributable Fraction of Epstein-Barr Virus in Subtypes of Lymphoma: A Systematic Review and Global Meta-Analysis.
   Int J Cancer. 2026 Apr 7. doi: 10.1002/ijc.70468.
   PubMed     Abstract available
   
   
   January 2026
2. ZUPUNSKI L, Yaumenenka A, Veyalkin I, Minenko V, et al
   Lymphoma, multiple myeloma and leukaemia incidence in regions of Belarus most heavily contaminated by the Chernobyl accident.
   Int J Cancer. 2026 Jan 23. doi: 10.1002/ijc.70346.
   PubMed     Abstract available
   
   
   
3. LI D, Li N, Huang S, Zhang M, et al
   Low T3 syndrome in children with aggressive mature B-cell non-Hodgkin lymphoma.
   Int J Cancer. 2026 Jan 17. doi: 10.1002/ijc.70335.
   PubMed     Abstract available
   
   
   December 2025
4. ROSTGAARD K, Hamilton-Dutoit S, Lauridsen KL, Ottander L, et al
   Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.
   Int J Cancer. 2025 Dec 25. doi: 10.1002/ijc.70305.
   PubMed     Abstract available
   
   
   November 2025
5. WANG X, Yang W, Xing H, Wang X, et al
   The efficacy and survival impact of chidamide on angioimmunoblastic T-cell lymphoma based on Epstein-Barr virus stratification in the real world: A multicenter study.
   Int J Cancer. 2025 Nov 20. doi: 10.1002/ijc.70251.
   PubMed     Abstract available
   
   
   
6. EKBERG S, Glimelius I, Albertsson-Lindblad A, Smedby KE, et al
   Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma.
   Int J Cancer. 2025 Nov 5. doi: 10.1002/ijc.70220.
   PubMed     Abstract available
   
   
   
7. BARNA G, Szaloki G, Mark A, Hunyadi A, et al
   CD86, the double agent: Significance of CD86 expression in B-cell malignancies.
   Int J Cancer. 2025;157:1772-1780.
   PubMed     Abstract available
   
   
   October 2025
8. QIU L, Bai S, Cai J, Fang Y, et al
   Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
   Int J Cancer. 2025 Oct 4. doi: 10.1002/ijc.70186.
   PubMed     Abstract available
   
   
   September 2025
9. RAMASSAMY JL, Tortevoye P, Ntab B, Carles G, et al
   Adult T-cell leukemia/lymphoma in French Guiana (1990-2019): Epidemiology, clinical features, and HTLV-1 genetic diversity in the two main ethnic populations.
   Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70164.
   PubMed     Abstract available
   
   
   
10. MOORE A, Kane E, Teras LR, Machiela MJ, et al
    Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses.
    Int J Cancer. 2025 Sep 5. doi: 10.1002/ijc.70039.
    PubMed     Abstract available
    
    
    August 2025
11. ZHAO J, Zhang Y, Li K, Xu L, et al
    Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
    Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
    PubMed     Abstract available
    
    
    
12. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
    Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
    Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
    PubMed     Abstract available
    
    
    June 2025
13. LIU Y, Lin N, Yi S, Huang H, et al
    Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial.
    Int J Cancer. 2025;156:2158-2168.
    PubMed     Abstract available
    
    
    March 2025
14. DING J, Cheng X, Wang H, Sun Y, et al
    Prognosis prediction in non-Hodgkin lymphoma by assessing lymphoid organs uptake patterns using baseline (18)F-FDG PET/CT.
    Int J Cancer. 2025 Mar 24. doi: 10.1002/ijc.35412.
    PubMed     Abstract available
    
    
    
15. LIANG X, Wu Y, Lu W, Li T, et al
    Latent class analysis-derived classification improves the cancer-specific death stratification of lymphomas: A large retrospective cohort study.
    Int J Cancer. 2025;156:1131-1141.
    PubMed     Abstract available
    
    
    
16. KIM IE JR, Oduor C, Stamp J, Luftig MA, et al
    Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma.
    Int J Cancer. 2025 Mar 6. doi: 10.1002/ijc.35384.
    PubMed     Abstract available
    
    
    October 2024
17. JAIN R, Huda TI, Paul S, Chobrutskiy A, et al
    Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphoma.
    Int J Cancer. 2024 Oct 8. doi: 10.1002/ijc.35212.
    PubMed     Abstract available
    
    
    September 2024
18. DUELL J, Westin J
    The future of immunotherapy for diffuse large B-cell lymphoma.
    Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35156.
    PubMed     Abstract available
    
    
    
19. BASSIG BA, Shu XO, Friesen MC, Vermeulen R, et al
    Occupational exposure to benzene and risk of non-Hodgkin lymphoma in an extended follow-up of two population-based prospective cohorts of Chinese men and women.
    Int J Cancer. 2024 Sep 2. doi: 10.1002/ijc.35095.
    PubMed     Abstract available
    
    
    August 2024
20. DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al
    Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018.
    Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091.
    PubMed     Abstract available
    
    
    July 2024
21. SARATHKUMARA YD, Xian RR, Liu Z, Yu KJ, et al
    A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.
    Int J Cancer. 2024 Jul 12. doi: 10.1002/ijc.35072.
    PubMed     Abstract available
    
    
    May 2024
22. FEDELI U, Barbiellini Amidei C, Han X, Jemal A, et al
    Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Int J Cancer. 2024;154:1703-1708.
    PubMed     Abstract available
    
    
    March 2024
23. WANG X, Deng L, Ping L, Shi Y, et al
    Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34892.
    PubMed     Abstract available
    
    
    
24. TABORELLI M, Serraino D, Cimaglia C, Furian L, et al
    Cancer mortality after kidney transplantation: A multicenter cohort study in Italy.
    Int J Cancer. 2024;154:842-851.
    PubMed     Abstract available
    
    
    December 2023
25. LUO J, Hendryx M, Rohan TE, Saquib N, et al
    Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
    Int J Cancer. 2023 Dec 19. doi: 10.1002/ijc.34820.
    PubMed     Abstract available
    
    
    October 2023
26. DU Y, Wang Y, Li Q, Chang X, et al
    Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
    Int J Cancer. 2023 Oct 24. doi: 10.1002/ijc.34773.
    PubMed     Abstract available
    
    
    September 2023
27. LINDMARK G, Olsson L, Sitohy B, Israelsson A, et al
    qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
    Int J Cancer. 2023 Sep 12. doi: 10.1002/ijc.34718.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum